News

Harvard study finds more than 1 in 150 births end in stillbirths

Pregnancy drug Makena pulled from market The drug Makena, which is meant to reduce the risk of preterm birth, is being pulled from the market by its maker. (Natalia Kuzina/Getty Images/iStockphoto)

CAMBRIDGE, MA — A new Harvard study finds more than 1 in 150 births end in stillbirth. That is higher than the one in 175 births that the CDC published as the national average.

Researcher Jessica Cohen says there are disparities in zip codes with predominantly low-income households, and more than one in 100 pregnancies in areas with households that identify as Black.

The study also found that while most stillbirths had at least one clinical risk factor, like hypertension or diabetes, a sizable portion had no identified clinical risk factor.

0
Comments on this article
0

mobile apps

Everything you love about wsbradio.com and more! Tap on any of the buttons below to download our app.

amazon alexa

Enable our Skill today to listen live at home on your Alexa Devices!